 |
Previous Article | Next Article 
Volume 16, Number 17,
Issue of September 1, 1996
pp. 5488-5497
Copyright ©1996 Society for Neuroscience
Spatially Restricted Increase in Polysialic Acid Enhances
Corticospinal Axon Branching Related to Target Recognition and
Innervation
Maryellen M. Daston1,
Martin Bastmeyer1,
Urs Rutishauser2, and
Dennis D. M. O'Leary1
1 Molecular Neurobiology Laboratory, The Salk
Institute, La Jolla, California 92037, and 2 Department of
Genetics and Neurosciences, Case Western Reserve University, Cleveland,
Ohio 44106
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The polysialic acid (PSA) modification of the neural cell adhesion
molecule (NCAM) has been shown to alter the responses of developing
axons to their environment. We have studied the potential role of PSA
in regulating the innervation of the spinal cord by corticospinal
axons, which occurs by a delayed formation of collateral branches from
the parent axons. Developmental changes in the distribution of PSA were
examined immunohistochemically using light and electron microscopy.
Whereas NCAM is distributed along the entire pathway of rat
corticospinal axons as they grow from the cortex to the spinal cord,
PSA-modified NCAM does not become evident until later. When PSA becomes
evident, it is restricted to the distal segment of these axons from the
caudal hindbrain through the spinal cord. The increase in PSA on
corticospinal axons coincides with the time that they begin to form
collateral branches in the spinal cord. This unique spatiotemporal
distribution of PSA suggests its involvement in corticospinal axon
branching. To test this hypothesis, PSA was selectively removed by an
in vivo injection of endoneuraminidase N. This treatment
did not seem to interfere with the pathfinding of corticospinal axons;
however, PSA removal delayed the onset of collateral branching by
corticospinal axons within the spinal cord and later diminished the
magnitude of branching. These findings indicate a role for PSA in the
regulation of interstitial axon branching, a crucial step in the
process of target recognition and innervation by corticospinal
axons.
Key words:
axon branching;
axon collaterals;
axon pathfinding;
axon
targeting;
basilar pons;
cell-cell interactions;
corticospinal tract;
endoneuraminidase N;
immunoelectron microscopy;
neural cell adhesion
molecules;
spinal cord
INTRODUCTION
Layer 5 cortical neurons innervate their targets
in the midbrain, hindbrain, and spinal cord by the process of
``interstitial axon branching'' (O'Leary and Terashima, 1988 ;
O'Leary et al., 1990 ; Kuang and Kalil, 1994 ; Bastmeyer and O'Leary,
1996 ). Instead of elaborating an axon that grows toward and into a
target, layer 5 cortical neurons extend axons that grow past their
targets and remain within their axon tract. Subsequently, collateral
branches arise de novo along these axons well behind their
advancing growth cones, exit the tract, and grow into their target
(Bastmeyer and O'Leary, 1996 ). The importance of interstitial axon
branching as a mode of target recognition and innervation is becoming
increasingly apparent as more examples are characterized, including the
development of the axonal projection from the hippocampal formation to
the mammillary bodies (Stanfield et al., 1987 ), the retina to the
lateral geniculate nucleus (Bhide and Frost, 1991 ) and tectum (Nakamura
and O'Leary, 1989 ), and the dorsal root ganglia to the spinal cord
(Snider et al., 1992 ).
The ability of an axon to respond to signals that promote the formation
and directed extension of collateral branches could be regulated by
factors that modify axon-axon or axon-substrate interactions. One of
the most abundant axonal adhesion molecules, the neural cell adhesion
molecule (NCAM) can be modified by the addition of polysialic acid
(PSA). The degree of polysialation of NCAM is regulated developmentally
(Hoffman et al., 1982 ; Rothbard et al., 1982 ), and in general,
increases in PSA correspond to periods of axon growth and pathfinding
(Rougon et al., 1982 ; Chuong and Edelman, 1984 ; Landmesser et al.,
1990 ; Tang et al., 1992 ). PSA on NCAM has been proposed to attenuate
cell-cell or cell-substrate interactions mediated by NCAM and by
other cell-surface molecules such as L1 (Rutishauser, 1989 ). A role for
PSA in axon pathfinding and target innervation has been indicated by
studies in chick, which show that the enzymatic removal of PSA from
growing motor axons interferes with their sorting in the limb plexus
and the formation of appropriately patterned peripheral nerves to
target muscles (Landmesser et al., 1990 ; Tang et al., 1992 , 1994 ).
Joosten (1994) recently described a developmental increase in PSA in
the corticospinal tract (CST) within the spinal cord, leading him to
suggest that PSA may facilitate the branching of corticospinal axons,
an issue that we examine here. First, we extended his observations by
examining the distribution of PSA along the entire pathway of
developing corticospinal axons from the forebrain to the spinal cord.
We have found using immunohistochemistry and immunoelectron microscopy
that PSA is localized to the distal segment of corticospinal axons and
that PSA becomes prominent after corticospinal axons have essentially
completed their phase of pathfinding but coincident with the onset of
collateral branching. To test whether PSA is involved in the
innervation of the spinal cord, we used the specific enzyme
endoneuraminidase N to selectively remove PSA in vivo and
examined the formation of collateral branches by corticospinal axons in
the absence of PSA.
MATERIALS AND METHODS
Animals
Rat pups were obtained from timed-pregnant Sprague-Dawley rats
purchased from Harlan Sprague-Dawley (Indianapolis, IN). The time of
birth was monitored closely. The first 24 hr after birth was considered
postnatal day 0 (P0). Rat pups were anesthetized by hypothermia before
all procedures. Embryonic day 20 (E20) fetuses were removed by cesarian
section from a pregnant rat deeply anesthetized with Nembutal.
Immunohistochemistry
Light microscopy. Two primary antibodies were used to
analyze the distributions of NCAM and PSA: the mouse monoclonal
antibody (mAb) 5A5, which recognizes the PSA moiety (Dodd et al., 1988 ;
Acheson et al., 1991 ), and a rabbit polyclonal, R050, which was made
against affinity-purified NCAM derived from mouse brain and recognizes
all isoforms of rat NCAM.
Rat pups were perfused through the left ventricle with 4%
paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4. After perfusion, brains and spinal cords were dissected and placed into
the same fixative overnight at 4°C. Tissue was then cryoprotected by
equilibration in 20% sucrose in PB; 10-12 µm cryostat sections were
cut and dried onto gelatin-subbed slides. Sections were treated for 30 min with blocking buffer (PBS with 10% normal goat serum) followed by
overnight incubation at 4°C with primary antibodies diluted in
blocking buffer. Sections were washed with PBS, incubated for 1 hr at
room temperature in the appropriate fluorescent-conjugated secondary
antibodies (Jackson ImmunoResearch, West Grove, PA), which were also
diluted in blocking buffer, and then mounted in Mowiol with
n-propyl gallate added to prevent fading.
Electron microscopy. P6 rat pups were perfused with 4%
paraformaldehyde/0.2% glutaraldehyde in 0.1 M
Sörensen's phosphate buffer (SPB), pH 7.4. The spinal cords were
dissected, postfixed for 1 hr in the same fixative at 4°C, and cut
into 200-µm-thick sections on a vibratome. The sections were
freeze-thawed by lowering them into liquid nitrogen for 2-5 sec,
treated with 10% normal goat serum in SPB for 1 hr, and incubated
overnight at room temperature with mAb 5A5, or for controls, with SPB
alone. After three washes in SPB, sections were processed for
peroxidase histochemistry using the ABC Elite kit (Vector, Burlingame,
CA) essentially as described by Liu et al. (1993) , except that SPB was
used in all steps. Sections were developed with 0.5% DAB, 0.1%
H2O2 in SPB for 5-10 min. After three washes
in SPB, they were postfixed in 3% glutaraldehyde in SPB for 30 min and
in 1% OsO4, 1.5% potassium ferrocyanide in SPB for 2 hr.
Sections were dehydrated in a graded series of ethanol and embedded in
Durcupan resin (Fluka, Buchs, Switzerland). Ultrathin sections (70 nm)
were cut, poststained with Reynolds lead citrate, and viewed and
photographed with a JEOL transmission electron microscope.
In vivo injection of endoneuraminidase N (endo N)
The endo N used in this study was purified from bacteriophage
(Hallenbeck et al., 1987 ). This preparation does not exhibit toxicity
for cells in culture or in vivo and does not contain
detectable amounts of protease activity. It acts optimally at pH 7, does not require cofactors, and specifically cleaves 2,8-linked
sialic acid polymers with a minimum chain length of eight (Vimr et al.,
1984 ; Hallenbeck et al., 1987 ). The enzyme is specific for PSA and has
no activity toward other sialic acid-containing components. When
injected in vivo in vertebrate embryos, endo N has been
shown to completely remove PSA over wide expanses of developing tissue
(Landmesser et al., 1990 ; Tang et al., 1992 , 1994 ).
Endo N was injected into the fourth ventricle of P0 rats, within 2-5
hr of birth. To gain access to the fourth ventricle, an incision was
made in the skin at the back of the skull, and the neck muscles were
reflected to expose the occipitoatlantal ligament. A glass micropipette
pulled to a fine tip containing endo N (or heat-inactivated endo N) was
used to puncture the ligament. One microliter of enzyme solution was
then introduced into the fourth ventricle through the micropipette
using a picospritzer (General Valve, Fairfield, NJ). For sham
injections, the same surgery was performed, and the ligament was
punctured using an empty micropipette. After injections the wound was
sutured, and rat pups were returned to their mothers after recovery
from hypothermia anesthesia.
Anterograde labeling of CST axons
1,1 -Dioctodecyl-3,3,3 ,3 -tetramethylindocarbocyanine
perchlorate (DiI) labeling. To label corticospinal axons
fluorescently, endo N-treated rat pups and control littermates received
bilateral injections of 10% DiI (Molecular Probes, Eugene, OR) (Honig
and Hume, 1989 ) in dimethyl formamide in sensorimotor cortex 2 d
before they were killed (P2, P3, or P4). Rat pups were perfused at P4,
P5, or P6 (all pups of a given litter were perfused at the same age)
with 10% neutral-buffered formalin. Brains and spinal cords were
dissected and placed in the same fixative and stored at 4°C for 24 hr
or longer. Spinal cords were flattened in the dorsoventral plane
between two glass slides with spacers of the same thickness as the
spinal cords before postfixation to eliminate the natural curvature of
the spinal cord. Flattening the spinal cords made it possible to obtain
horizontal sections in which the CST did not pass in and out of the
plane of section. The rostral halves of the spinal cords were cut in
100 µm horizontal sections using a vibratome. DiI-labeled CST axons
were examined and photographed using rhodamine optics.
Biocytin labeling. Rat pups that had been injected with endo
N (or control injections) on P0 received cortical biocytin injections
on P4 18-20 hr before perfusion on P5. Injections of 5% biocytin
(Sigma, St. Louis, MO) in 0.9% NaCl were made in sensorimotor cortex.
In each hemisphere, three injections were made along the coronal
suture. After perfusion, brains and spinal cords were prepared as
described above for DiI-injected animals. Brains and spinal cords were
cryoprotected and frozen (as for immunohistochemistry), and
50-µm-thick horizontal serial sections of the rostral half of the
spinal cords were cut using a freezing microtome. The sections were
mounted and dried onto gelatin-subbed slides. To visualize
biocytin-labeled axons, peroxidase histochemistry using the ABC Elite
kit (Vector) was carried out essentially as described in Liu et al.
(1993) , except that tissue sections were mounted on slides before
processing and PBS was used in all steps. In addition, a biotinyl
tyramine amplification step (Adams, 1992 ) was added.
Quantification of branching
For each spinal cord a complete series of sections containing
the entire CST was examined. The number of labeled axons was determined
by counting every axon that intersected a transverse line 600 µm
caudal to the hindbrain/spinal cord boundary. The number of branches
was determined by counting all branch points along labeled CST axons
within the rostral 6 mm of the spinal cord.
RESULTS
Distribution of PSA in the developing CST
Immunohistochemistry was used to determine the temporal and
spatial pattern of PSA distribution in the developing corticospinal
pathway. The mAb 5A5, which recognizes the PSA moiety, and the
polyclonal antibody R050, which recognizes all isoforms of rat NCAM,
were used to double-immunolabel sections of late embryonic and early
postnatal rat brains and spinal cords, the period during which
corticospinal axons grow through their subcortical pathway and extend
collateral branches to their brainstem and spinal targets (Stanfield,
1992 ; O'Leary and Koester, 1993 ). The pathway of layer 5 corticospinal
axons from the cortex to the spinal cord is schematically illustrated
in Figure 1.
Fig. 1.
Drawings depicting the CST and anatomical
structures relevant to this study. A, Sagittal view of
an early postnatal rat brain illustrating the pathway of corticospinal
axons, which originate from cortical layer 5 (L5)
neurons, and the location of collateral branches related to some of
their major subcortical targets. The locations and planes of section of
subsequent figures are indicated. The shaded boxes
surrounding the basilar pons (BP) and the pyramidal
decussation (pd) indicate the location of the
sagittal sections shown in Figure 2A-D and
E, F, respectively. The arrow marked
T approximates the location of the transverse sections
shown in Figures 3 and 6. The arrow marked
H approximates the location of the horizontal sections
shown in Figure 7. B, Schematic of a transverse section
through the spinal cord (marked by the arrow T in
A). The lines extending from the
two black dots depict branches (lines)
extending laterally into the spinal gray (SG) from
parent corticospinal axons (black dots) located in the
corticospinal tract (cst), which is in the ventral part
of the dorsal funiculus (df). The dashed
box and the shaded box indicate the approximate
locations of the panels illustrated in Figures 3 and 6, respectively.
C, Schematic of a horizontal section through the spinal
cord (marked by the arrow H in A) as in
Figure 7. Depicted are four branches extending laterally into the
spinal gray from two parent corticospinal axons coursing rostrocaudally
through the left CST. Abbreviations: BP, basilar pons;
cp, cerebral peduncle; cst, corticospinal
tract; df, dorsal funiculus; ic, internal
capsule; lat, lateral; L5, layer 5;
mid, midline; pd, pyramidal decussation;
pt, pyramidal tract; SG, spinal gray;
SpCd, spinal cord.
[View Larger Version of this Image (30K GIF file)]
At E20, the leading corticospinal axons have reached the level of the
basilar pons (O'Leary and Terashima, 1988 ). At this age, however,
staining for PSA was detected only in the internal capsule, where
corticospinal axons commingle with thalamocortical axons. PSA in the
internal capsule may be associated with thalamocortical axons rather
than corticospinal axons, because it is not present at more distal
positions within the forebrain where the corticospinal pathway becomes
distinct (not shown). Even at later ages, PSA staining was not observed
over the portion of the corticospinal pathway through the brainstem.
For example, PSA staining was absent in the corticospinal pathway over
the basilar pons at P0 (Fig. 2A),
when corticospinal axons begin to extend collateral branches to the
pons, and at P4 (Fig. 2C), when branching to the basilar
pons is essentially complete. Staining for NCAM, however, was present
throughout the brainstem corticospinal pathway at all ages examined
(Fig. 2B,D).
Fig. 2.
PSA is present caudally but not rostrally in
the developing CST. Sagittal sections of rat brains
double-immunostained for PSA (A, C, E) and NCAM
(B, D, F). A-D, PSA was not detectable
in the corticospinal tract (cst) (marked by black
lines) overlying the basilar pons (BP) at P0
(A) or P4 (C), or at E20 (not shown).
NCAM was abundant in the tract and in the surrounding area at each of
these ages (B, P0; D, P4). E,
F, At P4, PSA was present in the CST more caudally in the
hindbrain, where PSA staining highlights the pyramidal decussation
(curved arrows) at the hindbrain-spinal cord junction
(E). PSA staining is also apparent in the dorsal
funiculus of the spinal cord (straight arrow). NCAM was
distributed throughout the hindbrain and spinal cord
(F). For each antibody, the same exposure times were
used for photographing and printing. Rostral is to the
left, and dorsal is at the top. The
approximate location and orientation of the panels is illustrated in
Figure 1A. Scale bar (shown in
F): 200 µm.
[View Larger Version of this Image (126K GIF file)]
In contrast to the lack of PSA staining within the corticospinal
pathway over the basilar pons, in the spinal cord PSA staining becomes
prominent specifically within the CST at the onset of axon
collateralization. In the rat spinal cord, the CST is a midline
structure located in the ventral-most portion of the dorsal funiculus.
Corticospinal axons enter the spinal cord before birth, and on P0 have
already extended beyond the cervical level of the spinal cord (Schreyer
and Jones, 1982 ). At both P0 (Fig. 3A) and P2
(Fig. 3C), PSA staining was weak in the cervical CST and in
the surrounding spinal gray. At P4, however, when corticospinal axons
begin to extend collateral branches to the spinal gray
(Lopez-Mascaraque and O'Leary, 1991 ), PSA staining was intense in the
cervical CST but remained weak in the surrounding spinal gray (Fig.
3E). Within the dorsal funiculus, the staining specifically
increased in the ventrally located CST and was low or absent in its
dorsal components, which contain ascending sensory axons (see Fig.
6A). At all of these ages, NCAM was abundant throughout
the dorsal funiculus as well as in the surrounding spinal gray
(Fig. 3B,D,F).
Fig. 3.
In the spinal cord, PSA increases in the
corticospinal tract (cst) at the time of corticospinal
axon branching. Transverse sections of rat cervical spinal cords
double-immunostained for PSA (A, C, E) and NCAM
(B, D, F). PSA staining is weak in the CST (outlined by
thick arrows in A; thin
arrow marks midline) and spinal gray at P0 (A)
and P2 (C). At P4, PSA staining is intense in the CST
but remains weak in the surrounding spinal gray (E).
NCAM is abundant in the CST and the surrounding spinal gray at P0
(B), P2 (D), and P4 (F).
The approximate location and orientation of the panels are illustrated
in Figure 1, A (arrow marked
T) and B (dashed box).
Dorsal is to the top. Scale bar, 100 µm.
[View Larger Version of this Image (162K GIF file)]
Fig. 6.
Endoneuraminidase N eliminates PSA in the CST.
Transverse sections of P5 thoracic spinal cords, from rats treated at
birth with heat-inactivated endo N (A, B) or active endo
N (C, D), were double-immunostained for PSA (A,
C) and NCAM (B, D). In control spinal cords,
intense PSA staining is localized to the CST (arrow in
A; the remainder of the dorsal funiculi are outlined by
a dashed line and have much lower immunostaining for
PSA), whereas intense NCAM staining is present throughout the spinal
cord (B). Endo N treatment eliminates PSA
immunoreactivity (C), but NCAM staining is unchanged
(D). Dorsal is to the top, lateral to the
sides. The midline is at the middle of
each panel. The approximate location and orientation of the panels is
illustrated in Figure 1B (shaded box).
Scale bar (shown in D): 100 µm.
[View Larger Version of this Image (131K GIF file)]
The rostral-most location of detectable PSA staining within the
corticospinal pathway was the caudal hindbrain. At P4, when there was
no detectable PSA staining in the corticospinal pathway in rostral
hindbrain or over the basilar pons (Fig. 2C), PSA staining
in the caudal hindbrain highlighted the pyramidal decussation (Fig.
2E), although the staining appeared to be less intense than
that in the spinal cord. Again, this spatial difference in PSA
distribution does not reflect a difference in the distribution of NCAM,
which was present throughout the hindbrain (Fig. 2F).
To determine whether this unique spatiotemporal distribution of PSA in
the corticospinal pathway is attributable to a differential
distribution of PSA on corticospinal axons or on other cell types in
the tract, we used immunoelectron microscopy for subcellular PSA
localization. Figure 4 shows electron micrographs of the
CST of a P6 rat immunostained with mAb 5A5. Immunoreactivity was
localized to the extracellular surface of axonal membranes. PSA
immunoreactivity was not associated with the surfaces of other cellular
components of the tract, which include immature glia and endothelial
cells, except where they were apposed to axons.
Fig. 4.
PSA is selectively localized to axonal surfaces in
the CST. Pre-embedding immunoelectron microscopy with an anti-PSA mAb
and HRP-coupled secondary antibodies. A, C, Transverse
section of P6 rat cervical spinal cord through the CST demonstrates
that PSA immunoreactivity (black reaction product in intercellular
spaces between the membranes of apposing axons) is associated with
axonal profiles. PSA immunoreactivity is not associated with
endothelial (e) or glial (g) cell
processes except where they are adjacent to axons. B, D,
Control section treated in the same way but without primary antibody.
Scale bars: A, B, 1 µm; C, D, 0.25 µm.
[View Larger Version of this Image (122K GIF file)]
These findings on the distribution of PSA-modified NCAM, summarized in
Figure 5, indicate that PSA is distributed selectively
to the distal portion of corticospinal axons, and rather than being
present on the growing axons, PSA increases substantially at the time
that corticospinal axons begin to form collateral branches to the
spinal gray.
Fig. 5.
Developmental sequence of collateral branch
formation and PSA expression on corticospinal axons. Corticospinal
axons reach the basilar pons at E20 and form the first collateral
branches to the pons at P0. In the spinal cord, collateral branch
formation starts at P4. Whereas NCAM is present along the entire length
of corticospinal axons at all ages, PSA is found only on the distal
portion of these axons and only at later stages of their development.
E20-P0, PSA is not detected on corticospinal axons as
they grow from cortex to the spinal cord. P4-P6, PSA is
upregulated on a restricted distal portion of corticospinal axons
starting near the pyramidal decussation. The spatiotemporal dynamics of
PSA localization on corticospinal axons correlates with their formation
of collateral branches to the spinal gray. Refer to Figure
1A for the anatomical context of these axons
within the brain and spinal cord. Abbreviations: BP,
basilar pons; cp, cerebral peduncle; cst,
corticospinal tract; df, dorsal funiculus;
ic, internal capsule; L5, layer 5;
pd, pyramidal decussation; pt, pyramidal
tract; SG, spinal gray; SpCd, spinal
cord.
[View Larger Version of this Image (14K GIF file)]
PSA removal affects corticospinal axon branching in the
spinal cord
The spatiotemporal distribution of PSA suggests that it might
influence the innervation of the spinal gray by corticospinal axons.
The following experiments were designed to test whether PSA may
regulate the branching of corticospinal axons in the spinal cord by
treating neonatal rats with endo N. The endo N used in this study was
purified free of any other enzymatic activity, resulting in an enzyme
that specifically degrades PSA without otherwise altering NCAM or
affecting any other sialic acid-containing structure (Vimr et al.,
1984 ; Rustishauser et al., 1985; Hallenbeck et al.,
1987 ) .
Endo N eliminates PSA in the CST
Rat pups were treated within hours of birth with endo N,
heat-inactivated endo N, or sham injections in the fourth ventricle.
Figure 6 shows examples of mAb 5A5 immunostaining of
spinal cord sections from littermates perfused at P5. PSA staining
appeared normal in the spinal cords of rat pups treated with
heat-inactivated endo N (Fig. 6A) or sham injections (not
shown), with intense staining localized to the CST. In every rat pup
injected with endo N (total = 21), PSA staining was completely
abolished in the spinal cord (Fig. 6C), whereas NCAM
staining appeared normal (Fig. 6B,D). Identical results were
seen when rat pups were sacrificed at P4 or P6 (not shown). These
findings demonstrate that a single injection of endo N at P0 eliminates
PSA throughout the spinal cord for at least the period of time covered
in this study.
Removal of PSA reduces collateral branching of corticospinal axons
in the spinal cord
During normal development of the rat corticospinal projection,
corticospinal axons pass through the pyramidal decussation into the
spinal cord on P0 and begin to form collaterals at cervical levels on
P4. The collateral branches become more numerous during the following
several days (Lopez-Mascaraque and O'Leary, 1991 ). We treated rat pups
with endo N, heat-inactivated endo N, or sham injections on P0, and
later labeled corticospinal axons with cortical injections of
anterograde axonal tracers during the early and intermediate phases of
collateral branching to determine whether PSA removal affected this
process. The cervical portions of the spinal cords were used to assess
axon branching. A segment of each spinal cord, taken from the
mid-thoracic level, was used for anti-PSA immunostaining to verify the
effectiveness of the endo N treatment (Fig. 6).
To assess qualitatively the effect of PSA removal, we injected DiI in
sensorimotor cortex on P2 to label a large number of corticospinal
axons. Rat pups were perfused at P4, P5, or P6. A total of 21 animals
from three litters were used in this set of experiments (P4: four endo
N and two heat-inactivated endo N; P5: four endo N, two
heat-inactivated endo N, and two sham-injected; P6: five endo N, one
heat-inactivated endo N, and one sham-injected). The corticospinal
pathway in the endo N-treated rats appeared the same as that in normal
littermates. We did not observe any unusual tendency for labeled axons
to stray from the CST, nor other evidence for pathfinding errors (not
shown). In contrast to this similarity in the trajectories of the
parent corticospinal axons, we found a significant difference between
endo N-treated and normal rats in the onset and magnitude of
corticospinal axon branching in the spinal cord. Figure
7 shows comparisons of axonal branching in the cervical
region of spinal cords of control animals (left) and endo
N-treated (right) littermates at P4, P5, and P6. At P4,
collateral branches were clearly seen to extend laterally from the CST
into the spinal gray in control animals; however, few or no branches
were seen in endo N-treated littermates. In spinal cords examined at P5
and P6, collateral branches were present in endo N-treated animals but
were more sparse compared to control littermates. These findings show
that endo N treatment does not prevent the collateral branching of
corticospinal axons, but instead attenuates branch formation as well as
delays its onset.
Fig. 7.
Removal of PSA delays and reduces collateral
branching along corticospinal axons in the spinal cord. Horizontal
sections (100 µm thick) through the CST of cervical spinal cords
showing DiI-labeled corticospinal axons in control rats (left
side) and endo N-treated littermates (right
side) at P4, P5, and P6. Spinal cords with similar densities of
labeled corticospinal axons were chosen for comparison. Sections were
matched on the basis of their dorsoventral position within the spinal
cord. At P4, in control animals collateral branches
(arrows) extend laterally from the CST into the spinal
gray; however, few or no branches were seen in endo N-treated
littermates. At P5 and P6, collateral branches were present in
endo N-treated animals but were more sparse compared with control
littermates. Each panel shows one side of the spinal cord; the CST is
at the midline of the spinal cord, and the branches extend laterally
from it into the spinal gray. Rostral is to the top. The
approximate location and orientation of these panels are
illustrated in Figure 1, A (arrow marked
H) and C. Scale bar, 200 µm.
[View Larger Version of this Image (90K GIF file)]
DiI labeling of corticospinal axons resulted in a large number of
labeled axons and was useful in gaining a qualitative impression of the
extent of corticospinal axon branching. To facilitate quantification of
the effect of endo N treatment on axon branching, biocytin was used to
anterogradely label corticospinal axons. The lower density of labeled
axons made it possible to count both axon numbers and individual branch
points (Fig. 8A). Because at P4 we had found
essentially an absolute difference in branching between endo N-treated
and control animals, with no branching in the endo N-treated cases
compared to considerable branching in the control cases, we focused on
quantifying axonal branching at P5, an age when collaterals were
observed in both endo N-treated and control spinal cords. Pups from two
litters were treated at P0 with endo N (n = 9) or used
as controls (sham injections, n = 7; heat-inactivated
endo N, n = 2), labeled later with biocytin, and then
analyzed at P5. The number of branches per labeled axon ranged from
0.30 to 1.38 with a mean of 0.72 ± 0.11 SEM in endo N-treated
animals (375 axons analyzed), and from 0.42 to 1.98 with a mean of
1.09 ± 0.16 SEM in control animals (426 axons analyzed). Thus,
endo N treatment resulted in a statistically significant reduction of
34% in the mean number of branches/axon (Student's t test;
t = 1.88; df= 16; p < 0.05; Fig.
7B). Because in every case the endo N treatment removed all
immunohistochemically detectable PSA from the spinal cord, the overlap
between these two populations is likely attributable to the inherent
developmental variability normally observed among individuals rather
than differences in the effectiveness of the endo N treatment. These
results indicate that the reduction in corticospinal axon branching in
the spinal cord after endo N treatment is specific and attributable to
the selective removal of PSA.
Fig. 8.
Quantification of the effect of PSA removal on
corticospinal axon branching in the spinal cord. Because few or no
branches were evident in the P4 endo N-treated cases, we focused on
quantifying axonal branching at P5, an age when collateral branches
were observed in both endo N-treated and control spinal cords.
A, Horizontal sections (50 µm thick) through the CST
of P5 cervical spinal cord showing biocytin-labeled corticospinal
axons. The lower density of axons labeled with biocytin compared to DiI
made it possible to discern and count both axons and branch points
(arrow). Scale bar, 50 µm. B, Endo N
treatment resulted in a statistically significant 34%
reduction in the average number of branches/axon normally present at
P5. Bars indicate SEM.
[View Larger Version of this Image (90K GIF file)]
DISCUSSION
By examining the normal pattern of PSA distribution in the
developing corticospinal pathway and by assessing the effects of
enzymatically removing PSA in vivo, we have provided
evidence that PSA regulates the collateral branching of corticospinal
axons. PSA is not present initially on growing corticospinal axons, but
is later selectively upregulated only on the spinal segment of these
axons at the time they begin to form collateral branches to the spinal
gray. The selective removal of PSA delays the onset of collateral
branching by corticospinal axons within the spinal cord and later
diminishes the magnitude of their branching. These findings are
consistent with the notion that PSA modifies axonal responses to
external stimuli rather than directly stimulating axonal responses.
We chose to use an enzymatic removal of PSA with endo N for this study
because it completely abolishes PSA for extended periods of time,
leaves the NCAM polypeptide intact, and is nontoxic (Hallenbeck et al.,
1987 ; Rutishauser, 1989 ). An alternative approach would have been to
use a knockout mouse lacking all isoforms of NCAM (Cremer et al., 1994 )
or specifically NCAM 180 (Tomasiewicz et al., 1993 ). The predominant
reported anatomical defect in these mice, an abnormally small olfactory
bulb that results from an aberrant migration of precursor cells from
the telencephalic neuroepithelium, is apparently attributable to the
lack of PSA, because the knockout mice lack PSA in the olfactory bulb
and the mutant phenotype can be mimicked by enzymatic removal of PSA
(Ono et al., 1994 ). A priori, however, endo N treatment is a more
straightforward strategy for selectively studying the functions of PSA,
because it clearly dissociates the effect of PSA removal from the
effect of NCAM removal.
Heterogeneity in the distribution of PSA-modified NCAM on individual
cells has been shown previously for retinal ganglion cells, which have
PSA along the entire length of their axons but not on their cell bodies
(Schlosshauer et al., 1984 ). An important feature of PSA expression in
the corticospinal pathway is its differential distribution along
corticospinal axons. Similarly, some axonal glycoproteins, such as
TAG-1 and L1 on rat spinal cord commissural axons (Dodd et al., 1988 )
and fasciclins on insect neurons (Bastiani et al., 1987 ; Patel et al.,
1987 ), have been localized to specific axon segments. PSA is distinct
from these examples, however, in that it involves the discontinuous
distribution of a post-translational modification and not necessarily
the polypeptide. The localization of PSA to one portion of
corticospinal axons could be achieved in at least two ways. The PSA
modification could be restricted to an NCAM isoform that is not
uniformly distributed. Indeed, both major transmembrane forms of NCAM
(NCAM-140 and NCAM-180) can assume a polarized or nonuniform
distribution on cells (Persohn et al., 1989 ; Gunderson et al., 1993 ),
and the specific targeting of PSA to distinct regions of myotube cell
surfaces reflects the differential distribution of the lipid-linked
form of NCAM (i.e., NCAM-120) to which the PSA is attached (Fredette et
al., 1993 ). In the olfactory bulb, PSA is associated with NCAM 180 (Ono
et al., 1994 ), but it is not known which NCAM isoforms are involved in
the upregulation of PSA in the CST. Alternatively, the PSA modification
of a homogeneously distributed NCAM isoform could be restricted to the
distal portion of an axon by either directed targeting of the
PSA-modified NCAM or by local differences in the modification of NCAM
after integration into the axonal membrane.
The developmental events leading to target innervation by corticospinal
axons seems to be similar in the brainstem and spinal cord (O'Leary et
al., 1990 ). In both cases, corticospinal axons extend out of the cortex
and along their subcortical pathway, bypassing their brainstem and
spinal targets. Subsequently, these targets are contacted by
collaterals that branch off of the axon shaft well behind the advancing
growth cone (O'Leary and Terashima, 1988 ; O'Leary et al., 1990 ; Kuang
and Kalil, 1994 ; Bastmeyer and O'Leary, 1996 ). Even though the process
of target innervation by corticospinal axons is similar within the
brainstem and spinal cord, axon collateralization at these distinct
sites seems to be regulated differentially, given the dramatic
difference in PSA content on NCAM distributed along corticospinal
axons. As an optimizer of responses to environmental cues, PSA may be
required only in situations in which axon fasciculation is strong
relative to external cues. Consistent with this suggestion, the
cross-sectional area of the CST is much greater overlying the basilar
pons than in the spinal cord, whereas axonal number is similar at these
two locations during development (M. M. Daston, M. Bastmeyer, and D. D. M. O'Leary, unpublished observations). Thus, the packing density of
corticospinal axons is much greater, and therefore fasciculation is
probably tighter in the spinal cord than in the pons. Another possible
explanation is that it may be more critical to generate branches at an
accelerated schedule and higher number in the spinal cord than in the
pons. This could be because the basilar pons is a relay station between
cortex and the cerebellum, whereas the corticospinal innervation more
directly controls motor output.
The chemical characteristics of PSA provide clues as to how it may
function in neural development. Estimates of the size of the PSA moiety
on highly sialated membranes suggest that the volume of PSA is several
times that of the NCAM polypeptide (Rutishauser et al., 1988 ). In
vitro, the removal of PSA from NCAM increases the rate of
aggregation of membrane vesicles (Hoffman and Edelman, 1983 ;
Rutishauser et al., 1985 ) and results in a fivefold increase in the
area of close membrane apposition between cells (Rutishauser et al.,
1988 ). Analysis of the physical properties of PSA on NCAM and at the
cell surface (Yang et al., 1992 , 1994 ) suggests that attenuation of
cell-cell interactions stems not only from the steric properties of
this carbohydrate, but also from its negative charge. In the chick PNS,
the inhibition of axonal fasciculation by PSA on NCAM can be accounted
for by the disruption of homophilic L1 binding. It has been suggested
that this disruption of L1 binding is attributable to the sizable
length of the PSA-modified NCAM moiety relative to the length of the
extracellular domain of L1, thereby diminishing homophilic L1
interactions between neighboring axons (Landmesser et al., 1990 ). L1 is
on corticospinal axons (Joosten and Gribnau, 1989 ) and could thus be
involved in PSA effects in this system as well.
During the period of axon branching, CST axons in the spinal cord are
surrounded almost entirely by other unmyelinated axons (Gorgels et al.,
1989 ; Joosten et al., 1989 ). Thus, in this system PSA removal must
exert its effects by altering relationships between neighboring axons.
The ability of PSA to modulate axon-axon interactions has been
demonstrated by both in vitro and in vivo
experiments. For example, PSA removal enhances the fasciculation of
neurites extended by cultured DRG neurons (Rutishauser et al., 1985 ).
Removal of PSA from motor axons during their innervation of chick
hindlimb muscles causes not only an increase in axon-axon bundling
among fast motor fibers, but also a decrease in axon sprouting among
slow motor fibers (Landmesser et al., 1990 ). It seems then that
axon-axon fasciculation or the ``escape'' of a growth cone in
forming a sprout is particularly susceptible to the removal of PSA.
PSA removal may exert its effect on corticospinal axon branching in one
of several ways. One possibility is that stronger interactions and
tighter axon fasciculation among CST axons attributable to PSA removal
may interfere mechanically with branch formation. Alternatively, PSA
removal may alter axonal responses to molecules that positively or
negatively regulate branching. For example, PSA removal could bring
axons into closer proximity, allowing for interactions with ligands on
adjacent corticospinal axons or on other cell types within the CST,
that inhibit branch formation. Another possibility is that PSA removal
might reduce interactions between axons and branch-promoting molecules.
In vitro studies suggest that the basilar pons releases a
soluble chemoattractant that can induce branching and directed growth
of corticospinal axons (Heffner et al., 1990 ; O'Leary et al., 1991 ;
Sato et al., 1994 ). The same or similar activity may be released by the
spinal gray (Joosten et al., 1991 , 1994 ). The neurotrophin NT-3 is
another potential branching cue, as it has been shown to induce
premature ``sprouting'' of corticospinal axons when introduced into
the spinal cords of early postnatal rats (Schnell et al., 1994 )
and can exert a tropic effect on cortical axons in vitro
(O'Leary and Daston, 1994 ). If a soluble target-derived branching
agent operates in CST development, PSA removal may diminish axon
branching by causing tighter axon fasciculation and restricting
diffusion of the branching agent into the CST. In any case, the normal
role of PSA may be to attenuate axonal interactions within the CST and
thereby allow branching cues to exert a greater influence on the axon
shaft.
FOOTNOTES
Received March 20, 1996; revised May 22, 1996; accepted June 12, 1996.
This work was supported by National Institutes of Health Grants P01
NS31249 (D.D.M.O.), R01 HD18369 (U.R.), and F32 NS09444-02 (M.M.D.),
and Deutsche Forschungsgemeinschaft Fellowship Ba 1034/4 (M.B.). We
thank Patrick Burrola (The Salk Institute) for expert technical
assistance with the immunoelectron microscopy.
Correspondence should be addressed to Dennis D. M. O'Leary, MNL-O, The
Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037.
Dr. Bastmeyer's present address: Universität Konstanz,
Fakultät für Biologie, Postfach 5560, D-78434 Konstanz,
Germany.
REFERENCES
-
Acheson A,
Sunshine JL,
Rutishauser U
(1991)
NCAM
polysialic acid can regulate both cell-cell and cell-substrate
interactions.
J Cell Biol
114:143-153 .
[Abstract/Free Full Text]
-
Adams JC
(1992)
Biotin amplification of biotin and
horseradish peroxidase signals in histochemical stains.
J Histochem Cytochem
40:1457-1463 .
[Abstract]
-
Bastiani MJ,
Harrelson AL,
Snow PM,
Goodman CS
(1987)
Expression of fasciclin 1 and 11 glycoproteins on
subsets of axon pathways during neuronal development in the
grasshopper.
Cell
48:745-755 .
[ISI][Medline]
-
Bastmeyer M,
O'Leary DDM
(1996)
Dynamics of target
recognition by interstitial axon branching along developing cortical
axons.
J Neurosci
16:1450-1459.
[Abstract/Free Full Text]
-
Bhide PG,
Frost DO
(1991)
Stages of growth of hamster
retinofugal axons: implications for developing axonal pathways with
multiple targets.
J Neurosci
11:485-504 .
[Abstract]
-
Chuong C-M,
Edelman GM
(1984)
Alterations in neural cell
adhesion molecules during development of different regions of the
nervous system.
J Neurosci
4:2354-2368 .
[Abstract]
-
Cremer H,
Lange R,
Christoph A,
Plomann M,
Vopper G,
Roes J,
Brown R,
Baldwin S,
Kraemer P,
Scheff S,
Bathels D,
Rajewsky K,
Wille W
(1994)
Inactivation of the N-CAM gene in mice results in
size reduction of the olfactory bulb and deficits in spatial learning.
Nature
367:455-459 .
[Medline]
-
Dodd J,
Morton SB,
Karagogeos D,
Yamamoto M,
Jessell TM
(1988)
Spatial regulation of axonal glycoprotein
expression on subsets of embryonic spinal neurons.
Neuron
1:105-116 .
[ISI][Medline]
-
Fredette B,
Rutishauser U,
Landmesser L
(1993)
Regulation and
activity-dependence of N-cadherin, NCAM isoforms and polysialic acid on
chick myotubes during development.
J Cell Biol
123:1867-1888 .
[Abstract/Free Full Text]
-
Gorgels TGMF,
DeKort EJM,
Van Aanholt HTH,
Nieuwenhuys R
(1989)
A quantitative analysis of the development of the
pyramidal tract in the cervical spinal cord in the rat.
Anat Embryol
179:377-385.
[Medline]
-
Gunderson D,
Powell SK,
Rodriquez-Boulan E
(1993)
Apical
polarization of NCAM in retinal pigment epithelium is dependent on
contact with the neural retina.
J Cell Biol
121:335-343.
[Abstract/Free Full Text]
-
Hallenbeck PC,
Vimr ER,
Yu F,
Bassier B,
Troy FA
(1987)
Purification and properties of a
bacteriophage-induced endo-N-acetylneuraminidase specific
for poly-alpha-2,8-sialosyl carbohydrate units.
J Biol Chem
262:3553-3561 .
[Abstract/Free Full Text]
-
Heffner CD,
Lumsden AGS,
O'Leary DDM
(1990)
Target control
of collateral extension and directional axon growth in the mammalian
brain.
Science
247:217-220 .
[Abstract/Free Full Text]
-
Hoffman S,
Edelman GM
(1983)
Kinetics of homophilic binding
by embryonic and adult forms of the neural cell adhesion molecule.
Proc Natl Acad Sci USA
80:5762-5766 .
[Abstract/Free Full Text]
-
Hoffman S,
Sorkin BC,
White PC,
Brackenbury R,
Mailhammer R,
Rutishauser U,
Cunningham BA,
Edelman GM
(1982)
Chemical
characterization of a neural cell adhesion molecule (NCAM) purified
from embryonic brain membranes.
J Biol Chem
257:7720-7729 .
[Abstract/Free Full Text]
-
Honig MG,
Hume RI
(1989)
DiI and DiO: versatile fluorescent
dyes for neuronal labeling and pathway tracing.
Trends Neurosci
12:333-341 .
[ISI][Medline]
-
Joosten EAJ
(1994)
Developmental expression of N-CAM epitopes
in the rat spinal cord during corticospinal tract axon outgrowth and
target innervation.
Dev Brain Res
78:226-236.
[Medline]
-
Joosten EAJ,
Gribnau AAM
(1989)
Immunocytochemical
localization of cell adhesion molecule L1 in developing rat pyramidal
tract.
Neurosci Lett
100:94-98.
[ISI][Medline]
-
Joosten EAJ,
Gribnau AAM,
Dederen PJWC
(1989)
Postnatal
development of the corticospinal tract in the rat: an ultrastructural
anterograde HRP study.
Anat Embryol
179:449-456.
[Medline]
-
Joosten EAJ,
van der Ven PFM,
Hooiveld MHW,
ten Donkelaar HJ
(1991)
Induction of corticospinal target finding by
release of a diffusible, chemotropic factor in cervical spinal grey
matter.
Neurosci Lett
128:25-28.
[ISI][Medline]
-
Joosten EAJ,
Gispen WH,
Bar PR
(1994)
Tropism and
corticospinal target selection in the rat.
Neuroscience
59:33-41.
[ISI][Medline]
-
Kuang RZ,
Kalil K
(1994)
Development of specificity in
corticospinal connections by collaterals branching selectively into
appropriate spinal targets.
J Comp Neurol
344:270-282 .
[ISI][Medline]
-
Landmesser L,
Dahm L,
Tang J,
Rutishauser U
(1990)
Polysialic
acid as a regulator of intramuscular nerve branching during embryonic
development.
Neuron
4:655-667 .
[ISI][Medline]
-
Liu W-L,
Behbehani MM,
Shipley MT
(1993)
Intracellular
filling in fixed brain slices using Miniruby, a fluorescent biocytin
compound.
Brain Res
608:78-86 .
[ISI][Medline]
-
Lopez-Mascaraque L,
O'Leary DDM
(1991)
Specificity and mode
of growth of developing corticospinal axons to their spinal gray
terminal fields.
Soc Neurosci Abstr
17:740.
-
Nakamura H,
O'Leary DDM
(1989)
Inaccuracies in initial
growth and arborization of chick retinotectal axons followed by course
corrections and axon remodeling to develop topographic order.
J Neurosci
9:3776-3795 .
[Abstract]
-
O'Leary DDM, Daston MM (1994) Neurotrophin-3 has a
chemotropic effect on cortical neurons. Soc Neurosci Abstr
20:1685a.
-
O'Leary DDM,
Koester SE
(1993)
Development of projection
neuron types, axon pathways, and patterned connections of the mammalian
cortex.
Neuron
10:991-1006.[ISI][Medline]
-
O'Leary DDM, Terashima T (1988) Cortical axons branch to
multiple subcortical targets by interstitial axon budding: implications
for target recognition and ``waiting periods.'' Neuron
1:901-910.
-
O'Leary DDM, Bicknese AR, De Carlos JA, Heffner CD, Koester SE, Kutka
LJ, Terashima T (1990) Target selection by cortical axons:
alternative mechanisms to establish axonal connections in the
developing brain. In: Cold Spring Harbor Symposia on Quantitative
Biology, vol LV, pp 453-367. Cold Spring Harbor, New York: Cold Spring
Harbor Laboratory.
-
O'Leary DDM,
Heffner CD,
Kutka L,
Lopez-Mascaraque L,
Missias A,
Reinoso BS
(1991)
A target-derived chemoattractant controls
the development of the corticopontine projection by a novel mechanism
of axon targeting.
Development [Suppl]
2:123-130.
-
Ono K,
Tomasiewicz H,
Magnuson T,
Rutishauser U
(1994)
N-CAM
mutation inhibits tangential neuronal migration and is phenocopied by
enzymatic removal of polysialic acid.
Neuron
13:595-609 .
[ISI][Medline]
-
Patel NH,
Snow PM,
Goodman CS
(1987)
Characterization and
cloning of fasciclin III: a glycoprotein expressed on a subset of
neurons and axon pathways in Drosophila.
Cell
48:975-988 .
[ISI][Medline]
-
Persohn E,
Pollerberg G,
E,
Schachner M
(1989)
Immunoelectron-microscopic localization of the 180 kDa component of the neural cell adhesion molecule NCAM in postsynaptic
membranes.
J Comp Neurol
288:92-100 .
[ISI][Medline]
-
Rothbard JB,
Brackenbury R,
Cunningham BA,
Edelman GM
(1982)
Differences in the carbohydrate structures of
neural cell adhesion molecules from adult and embryonic chicken brains.
J Biol Chem
257:11064-11069 .
[Abstract/Free Full Text]
-
Rougon G,
Deagostini-Bazin H,
Hirn M,
Giordis C
(1982)
Tissue
and developmental stage-specific forms of a neural cell-surface antigen
linked to differences in glycosylation of a common polypeptide.
EMBO J
1:1239-1244 .
[ISI][Medline]
-
Rutishauser U
(1989)
Polysialic acid as a regulator of cell
interactions.
In: Neurobiology of glycoconjugates
(Margolis, RU,
Margolis, RK,
eds)
, p. 367. New York: Plenum.
-
Rutishauser U,
Watanabe M,
Silver J,
Troy FA,
Vimr ER
(1985)
Specific alteration of NCAM-mediated cell adhesion
by an endoneuraminidase.
J Cell Biol
101:1842-1849 .
[Abstract/Free Full Text]
-
Rutishauser U,
Acheson A,
Hall AK,
Mann DM,
Sunshine J
(1988)
The neural cell adhesion molecule (NCAM) as a
regulator of cell-cell interactions.
Science
240:53-57 .
[Abstract/Free Full Text]
-
Sato M,
Lopez-Mascaraque L,
Heffner CD,
O'Leary DDM
(1994)
Action of a diffusible target-derived
chemoattractant on cortical axon branch induction and directed growth.
Neuron
13:791-803 .
[ISI][Medline]
-
Schlosshauer B,
Schwarz U,
Rutishauser U
(1984)
Topological
distribution of different forms of neural cell adhesion molecule in the
developing chick visual system.
Nature
310:141-143 .
[Medline]
-
Schnell L,
Schneider R,
Kolbeck R,
Barde YA,
Schwab MD
(1994)
Neurotrophin-3 enhances sprouting of corticospinal
tract axons during development and after adult spinal cord lesion.
Nature
367:170-173 .
[Medline]
-
Schreyer DJ,
Jones EG
(1982)
Growth and target finding by
axons of the corticospinal tract in prenatal and postnatal rats.
Neuroscience
7:1837-1853 .
[ISI][Medline]
-
Snider WD,
Zhang L,
Yusoof S,
Gorukanti N,
Tsering C
(1992)
Interactions between dorsal root axons and their
target motor neurons in developing mammalian spinal cord.
J Neurosci
12:3494-3508 .
[Abstract]
-
Stanfield BB
(1992)
The development of the corticospinal
projection.
Prog Neurobiol
38:169-202 .
[ISI][Medline]
-
Stanfield BB,
Nahin BR,
O'Leary DDM
(1987)
A transient
post-mamillary component of the rat fornix during development:
implications for interspecific differences in mature axonal
projections.
J Neurosci
7:3350-3361 .
[Abstract]
-
Tang J,
Landmesser L,
Rutishauser U
(1992)
Polysialic acid
influences specific pathfinding by avian motoneurons.
Neuron
8:1031-1044 .
[ISI][Medline]
-
Tang J,
Rutishauser U,
Landmesser L
(1994)
Polysialic acid
regulates growth cone behavior during sorting of motor axons in the
plexus region.
Neuron
13:405-414 .
[ISI][Medline]
-
Tomasiewicz H,
Ono K,
Yee D,
Thompson C,
Giordis C,
Rutishauser U,
Magnuson T
(1993)
Genetic deletion of a neural cell adhesion
molecule variant (N-CAM-180) produces distinct defects in the central
nervous system.
Neuron
11:1163-1174 .
[ISI][Medline]
-
Vimr ER,
McCoy RD,
Vollger HF,
Wilkinson NC,
Troy FA
(1984)
Use of prokaryotic-derived probes to identify
polysialic acid in neonatal membranes.
Proc Natl Acad Sci USA
81:1971-1975 .
[Abstract/Free Full Text]
-
Yang P,
Yin X,
Rutishauser U
(1992)
Intercellular space is
affected by the polysialic acid content of NCAM.
J Cell Biol
116:1487-1496 .
[Abstract/Free Full Text]
-
Yang P,
Major D,
Rutishauser U
(1994)
Role of charge and
hydration in effects of polysialic acid on molecular interactions on
and between cell membranes.
J Biol Chem
269:23039-23044 .
[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Lopez-Fernandez, M.-F. Montaron, E. Varea, G. Rougon, C. Venero, D. N. Abrous, and C. Sandi
Upregulation of Polysialylated Neural Cell Adhesion Molecule in the Dorsal Hippocampus after Contextual Fear Conditioning Is Involved in Long-Term Memory Formation
J. Neurosci.,
April 25, 2007;
27(17):
4552 - 4561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. El Maarouf, A. K. Petridis, and U. Rutishauser
Use of polysialic acid in repair of the central nervous system
PNAS,
November 7, 2006;
103(45):
16989 - 16994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Canty, U. Greferath, A. M. Turnley, and M. Murphy
Eph tyrosine kinase receptor EphA4 is required for the topographic mapping of the corticospinal tract
PNAS,
October 17, 2006;
103(42):
15629 - 15634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Rolf, M. Bastmeyer, M. Schachner, and U. Bartsch
Pathfinding Errors of Corticospinal Axons in Neural Cell Adhesion Molecule-Deficient Mice
J. Neurosci.,
October 1, 2002;
22(19):
8357 - 8362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Marx, U. Rutishauser, and M. Bastmeyer
Dual function of polysialic acid during zebrafish central nervous system development
Development,
December 15, 2001;
128(24):
4949 - 4958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Yamamoto, K. Inui, Y. Matsuyama, A. Harada, K. Hanamura, F. Murakami, E. S. Ruthazer, U. Rutishauser, and T. Seki
Inhibitory Mechanism by Polysialic Acid for Lamina-Specific Branch Formation of Thalamocortical Axons
J. Neurosci.,
December 15, 2000;
20(24):
9145 - 9151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ringstedt, J. E. Braisted, K. Brose, T. Kidd, C. Goodman, M. Tessier-Lavigne, and D. D. M. O'Leary
Slit Inhibition of Retinal Axon Growth and Its Role in Retinal Axon Pathfinding and Innervation Patterns in the Diencephalon
J. Neurosci.,
July 1, 2000;
20(13):
4983 - 4991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Saueressig, J Burrill, and M Goulding
Engrailed-1 and netrin-1 regulate axon pathfinding by association interneurons that project to motor neurons
Development,
January 10, 1999;
126(19):
4201 - 4212.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Seki and U. Rutishauser
Removal of Polysialic Acid-Neural Cell Adhesion Molecule Induces Aberrant Mossy Fiber Innervation and Ectopic Synaptogenesis in the Hippocampus
J. Neurosci.,
May 15, 1998;
18(10):
3757 - 3766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Bruses and U. Rutishauser
Regulation of Neural Cell Adhesion Molecule Polysialylation: Evidence for Nontranscriptional Control and Sensitivity to an Intracellular Pool of Calcium
J. Cell Biol.,
March 9, 1998;
140(5):
1177 - 1186.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|